Fran Curtis is a five-time survivor of cancers survivor including breast, appendix and skin cancer, but she told CURE in a ...
The report ‘Prostate Cancer Screening: The Impact on the NHS’ was published by Prostate Cancer Research at 00:01 UK time on Tuesday 14 October 2025.
Prevention is always better than cure, particularly with potentially life-threatening diseases. But when dealing with an ...
In the histology-centric world of cancer medicine, further work is needed to increase genomic testing rates and educate ...
AstraZeneca's Imfinzi with BCG delivers 32% lower recurrence risk in high-risk bladder cancer. Read more here.
Investigators evaluated stromal content in the tumor microenvironment as a marker for bladder cancer prognosis, including disease-free survival and overall survival.
Pfizer and Japanese firm Astellas' drug Padcev, combined with Merck's Keytruda, lowered the risk of tumor recurrence, ...
Merck (MRK) stock is in focus as the company's Keytruda versions win FDA priority review for an expanded indication in ...
NMIBC treatment varies by tumor stage, grade, and prior therapies, with high-risk cases often requiring radical cystectomy. Bladder-preserving approaches include intravesical therapies like BCG, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback